Amanote Research
Register
Sign In
Precision Epigenetic Therapy for B-Cell Lymphoma
Hematological Oncology
- United Kingdom
doi 10.1002/hon.2_2629
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
A. Melnick
Publisher
Wiley
Related search
Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers
Genes
Genetics
Nanoparticle-Based Strategy for Personalized B-Cell Lymphoma Therapy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Anti-Idiotypic DNA Vaccines for B-Cell Lymphoma Therapy
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Epigenetic Regulation of CD1d-mediated Antigen Presentation in B Cell Lymphoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Is Radiotherapy Still Necessary for Diffuse Large B-Cell Lymphoma Therapy?
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Choosing the Appropriate Salvage Therapy for B-Cell Non-Hodgkin Lymphoma
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
PLoS ONE
Multidisciplinary
Hematopoietic Cell Transplantation for B-Cell Lymphoma: An Update
Cancer Control
Medicine
Oncology
Hematology
Novel Drug Targets for Personalized Precision Medicine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Comprehensive Review
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine